MedPath

Effects of Table Tennis for People With Parkinson's Disease

Not Applicable
Recruiting
Conditions
Parkinson Disease
Interventions
Other: Exercise and cognitive training interventino
Registration Number
NCT06444685
Lead Sponsor
Universitat de Lleida
Brief Summary

Quasi-experimental, controlled, non-randomised two-arm pilot, with an experimental group (table tennis exercise) and an active control group (cognitive training based on board games).

Detailed Description

Quasi-experimental, controlled, non-randomised two-arm pilot, with an experimental group (table tennis exercise) and an active control group (cognitive training based on board games). Interventions in both groups will take place twice a week for 6 weeks (12 sessions in total). The main variables to be assessed will be motor and cognitive. As secondary variables, clinical and daily life aspects will be assessed. As results, it is expected that the experimental group will obtain improvements in motor variables compared to the control group after receiving the interventions. However, improvements in cognitive variables and secondary variables are expected to be similar in both groups.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Diagnosis of Parkinson's Disease based on the UK PD Society Brain Bank Criteria
  • Stage I to III on the Hoehn and Yahr scale
  • Ability to walk for 10 minutes unassisted
Exclusion Criteria
  • Score of under 23 on the Mini-Mental State Examination
  • Severe Visual or Auditory deficits
  • Cardiovascular conditions that impede physical activity
  • Brain surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tabletop GamesExercise and cognitive training interventinoParticipants will follow supervised Tabletop Game sessions lasting 60 minutes during 6 weeks, for a total of 12 sessions.
Table TennisExercise and cognitive training interventinoParticipants will follow supervised Table Tennis sessions lasting 60 minutes during 6 weeks, for a total of 12 sessions.
Primary Outcome Measures
NameTimeMethod
Amplitude of Center of Pressure under Dual Task conditions (Motor)Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

Assessment of amplitude of Center of Pressure (in mm) during balance testing under concurrent cognitive tasks (Motor, by holding a glass of water on a tray) using OPAL Sensors (APDM, Oregon, USA).

Amplitude of Center of Pressure under Dual Task conditions (Verbal)Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

Assessment of amplitude of Center of Pressure (in mm) during balance testing under concurrent cognitive tasks (Verbal, by naming words starting by a random letter) using OPAL Sensors (APDM, Oregon, USA).

Trail-Making TestAssessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

Assessment of Trail-Making Test parts A and B

Amplitude of Center of Pressure under simple conditionsAssessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

Assessment of amplitude of Center of Pressure (in mm) during balance testing using OPAL Sensors (APDM, Oregon, USA).

Amplitude of Center of Pressure under Dual Task conditions (Arithmetic)Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

Assessment of amplitude of Center of Pressure (in mm) during balance testing under concurrent cognitive tasks (Arithmetic, by concurrently substracting 7 from a random number) using OPAL Sensors (APDM, Oregon, USA).

Secondary Outcome Measures
NameTimeMethod
United Parkinson's Disease Rating Scale - Part IIIAssessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

Assessment of Motor symptoms of Parkinson's Disease with a predetermined assessment

Timed Up and Go testAssessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

Assessment of gait mobility and fall risk by getting up from a chair, walking 3 meters, turning back and sitting again.

Montreal Cognitive AssessmentAssessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

Assessment of cognitive status to detect Mild Cognitive Impairment with a preset questionnaire.

Falls Efficacy Scale InternationalAssessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

Assessment of perceived fall risk with a predetermined questionnaire.

Parkinson's Disease Questionnaire - 8Assessed before starting the intervention (T0) and 6 weeks later (T0 + 6 weeks).

Assessment of Quality of Life for people with Parkinson's Disease through a self-administered questionnaire

Trial Locations

Locations (1)

Institut de Recerca Biomèdica de Lleida

🇪🇸

Lleida, Spain

© Copyright 2025. All Rights Reserved by MedPath